Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Spring on the Road
Spring Wellness
Premier Home Stylle Tour 2024
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Cybin Inc.
< Previous
1
2
3
4
5
6
Next >
Cybin Announces FDA Investigational New Drug Authorization of Cybin’s Sponsored Feasibility Study Using Kernel Flow Technology
October 26, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Completion of 74 Pre-Clinical Psychedelic Molecule Studies
October 19, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Files an International Patent Application Covering Psychedelic Delivery Methods
October 12, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Additional Adelia Milestone Achievements
October 07, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Appointment of Dr. Amir Inamdar as Chief Medical Officer for European Operations and Dr. Geoff Varty as the Head of Research and Development
October 01, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Present at Upcoming Cantor and Benzinga Investor Conferences
September 27, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Present at the H.C. Wainwright 23rd Annual Global Investment Conference on September 13th
September 09, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Additional Adelia Milestone Achievements
August 31, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Files Two Additional International Patent Applications in Support of the Company’s Research Phase Programs
August 19, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Files 14th Patent Application Further Strengthening its IP Portfolio and Receives a Favorable Patent Claim Opinion
August 17, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Election of Theresa Firestone as Director, Results of Shareholders’ Meeting and Adoption of Shareholder Rights Plan
August 16, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Inc. Announces 2021 First Quarter Financial Results and Business Highlights
August 13, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
CORRECTING and REPLACING Cybin Announces Additional Adelia Milestone Achievements
August 12, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin Announces Additional Adelia Milestone Achievements
August 12, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Present at Canaccord Genuity’s 41st Annual Growth Conference on August 10th
August 09, 2021
From
Cybin Inc.
Via
Business Wire
Tickers
CYBN
Cybin to Commence Trading on the NYSE American on August 5
August 04, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Receives Final Approval to Commence Trading on the NYSE American on or About August 5
July 28, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares
July 28, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Announces Conditional Listing Approval from NYSE American
July 21, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Files its 13th Patent Application and Announces Digital Therapeutics Strategy
July 13, 2021
From
Cybin Inc.
Via
Business Wire
Cybin to Participate in Cowen’s Psychedelics & Novel Mechanisms in Neuropsychiatry Virtual Summit on July 13th
July 09, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Expands to Europe and Provides Update on Intellectual Property Portfolio
July 08, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence
July 06, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Announces Positive Pre-Clinical Results With Multiple Proprietary Psychedelic Molecules and Adelia Milestone Achievement
June 28, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Inc. Releases Annual Financials and Provides Business Highlights
June 28, 2021
From
Cybin Inc.
Via
Business Wire
Cybin to Participate in Grizzle Psychedelics Con on June 28th
June 25, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Announces Former FDA Psychiatry Division Director Dr. Thomas Laughren has Joined Clinical Advisory Board
June 24, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Announces Completion of its 51st Pre-Clinical Psychedelic Molecule Study
June 22, 2021
From
Cybin Inc.
Via
Business Wire
Cybin to Present at the Emerging Growth Conference on June 23rd
June 18, 2021
From
Cybin Inc.
Via
Business Wire
Cybin Selects Anxiety Disorder Indications for Proprietary Psychedelic Molecule CYB004
June 16, 2021
From
Cybin Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.